untitled
<OAI-PMH schemaLocation=http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd>
<responseDate>2018-01-15T18:17:44Z</responseDate>
<request identifier=oai:HAL:hal-01509561v1 verb=GetRecord metadataPrefix=oai_dc>http://api.archives-ouvertes.fr/oai/hal/</request>
<GetRecord>
<record>
<header>
<identifier>oai:HAL:hal-01509561v1</identifier>
<datestamp>2018-01-11</datestamp>
<setSpec>type:ART</setSpec>
<setSpec>subject:sdv</setSpec>
<setSpec>collection:CNRS</setSpec>
<setSpec>collection:UNIV-PICARDIE</setSpec>
<setSpec>collection:UNIV-AG</setSpec>
<setSpec>collection:UNIV-FCOMTE</setSpec>
<setSpec>collection:UPMC</setSpec>
<setSpec>collection:ICM</setSpec>
<setSpec>collection:UNIV-LEMANS</setSpec>
<setSpec>collection:UPMC_POLE_4</setSpec>
<setSpec>collection:CHRONO-ENVIRONNEMENT</setSpec>
</header>
<metadata><dc>
<publisher>HAL CCSD</publisher>
<title lang=en>Hints for control of infection in unique extrahepatic vertebral alveolar echinococcosis.</title>
<creator>Faucher, Jean-François</creator>
<creator>Descotes-Genon, Cécile</creator>
<creator>Hoen, Bruno</creator>
<creator>Godard, Joël</creator>
<creator>Félix, Sophie</creator>
<creator>Aubry, Sébastien</creator>
<creator>Blagosklonov, Oleg</creator>
<creator>Grenouillet, Frédéric</creator>
<creator>Brientini, Marie-Pascale</creator>
<creator>Richou, Carine</creator>
<creator>Bresson-Hadni, Solange</creator>
<creator>Chirouze, Catherine</creator>
<contributor>Université de Picardie Jules Verne (UPJV)</contributor>
<contributor>Centre d'Investigation Clinique Antilles-Guyane (CIC - Antilles Guyane) ; Université des Antilles et de la Guyane (UAG) - Institut National de la Santé et de la Recherche Médicale (INSERM) - CHU de Pointe-à-Pitre - Centre Hospitalier de Cayenne Andrée Rosemon - CHU de Fort de France</contributor>
<contributor>Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute (ICM) ; Université Pierre et Marie Curie - Paris 6 (UPMC) - Institut National de la Santé et de la Recherche Médicale (INSERM) - CHU Pitié-Salpêtrière [APHP] - Centre National de la Recherche Scientifique (CNRS)</contributor>
<contributor>Laboratoire d'acoustique de l'université du Mans (LAUM) ; Le Mans Université (UM) - Centre National de la Recherche Scientifique (CNRS)</contributor>
<contributor>SAFRAN [Paris] ; SAFRAN Group</contributor>
<contributor>Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon)</contributor>
<contributor>Laboratoire Chrono-environnement (LCE) ; Université Bourgogne Franche-Comté (UBFC) - Centre National de la Recherche Scientifique (CNRS) - Université de Franche-Comté (UFC)</contributor>
<contributor>WHO Collaborating Center on Prevention and Treatment of Human Echinococcosis ; Université de Franche-Comté (UFC)</contributor>
<contributor>Hôpital Jean Minjoz ; Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon)</contributor>
<contributor>Service des maladies infectieuses et tropicales ; Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon) - Hôpital Saint-Jacques</contributor>
<description>International audience</description>
<source>ISSN: 0300-8126</source>
<source>EISSN: 1439-0973</source>
<source>Infection</source>
<publisher>Springer Verlag</publisher>
<identifier>hal-01509561</identifier>
<identifier>https://hal.archives-ouvertes.fr/hal-01509561</identifier>
<source>https://hal.archives-ouvertes.fr/hal-01509561</source>
<source>Infection, Springer Verlag, 2016</source>
<identifier>PUBMED : 28004258</identifier>
<relation>info:eu-repo/semantics/altIdentifier/pmid/28004258</relation>
<language>en</language>
<subject lang=en>Alveolar echinococcosis</subject>
<subject lang=en>Cure</subject>
<subject lang=en>Therapeutic drug monitoring</subject>
<subject lang=en>Vertebral</subject>
<subject>[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology</subject>
<type>info:eu-repo/semantics/article</type>
<type>Journal articles</type>
<description lang=en>The prognosis of vertebral alveolar echinococcosis (AE) is poor. We report on the unique outcome of a patient with preexisting liver cirrhosis, in whom a diagnosis of vertebral AE was established on vertebral histopathology (D4 corporectomy in 2010 for paraplegia). Therapeutic drug monitoring of albendazole (ABZ) showed that a low dosage was appropriate. The patient recovered and ABZ withdrawal was decided in 2014, with no relapse 18 months later. In this patient, infection was purely or mainly localized in the dorsal spine, and this may have been favored by liver cirrhosis. A longer follow-up is, however, needed to confirm cure.</description>
<date>2016-12-21</date>
</dc>
</metadata>
</record>
</GetRecord>
</OAI-PMH>
